Portfolio Holdings Detail for ISIN IE000NITTFF2
| Stock Name / Fund | iShares Russell 1000 Growth UCITS ETF USD Acc |
| Issuer | Blackrock |
| Entity holding fund | iShares VII Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300Q7FFITMZ2PFZ28 |
| ETF Ticker | R1GR(USD) AS |
| ETF Ticker | R1GR(USD) Euronext Amsterdam |
Holdings detail for REGN
| Stock Name | Regeneron Pharmaceuticals Inc |
| Ticker | REGN(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US75886F1075 |
| LEI | 549300RCBFWIRX3HYQ56 |
Show aggregate REGN holdings
News associated with REGN
- Nasdaq 100 Movers: REGN, APP
- In early trading on Wednesday, shares of Applovin topped the list of the day's best performing components of the Nasdaq 100 index, trading up 9.3%. Year to date, Applovin has lost about 13.0% of its value.
And the worst performing Nasdaq 100 component thus far on the day is Re - 2025-03-12 14:53:06
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 14:11:53
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 12:59:09
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 12:43:03
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 12:36:09
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 12:17:44
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 11:00:07
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 10:46:56
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 10:44:43
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 10:32:04
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 08:55:20
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 06:54:49
- Stocks Fall on Growth Fears and Tech Stock Plunge
- The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini S&P futures (ESH25 ) fell -2.58%, and March E-mini Nasdaq futures (NQH25... - 2025-03-11 06:10:53
- Jones Financial Companies Lllp Has $578,000 Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
- Jones Financial Companies Lllp increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 107.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 812 shares of the biopharmaceutical company’s stock after acquiring an additional 421 shares during […] - 2025-03-10 08:06:59
- Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Price Target at $973.13
- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average rating of “Moderate Buy” from the twenty-five analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation, sixteen have given a buy recommendation and two have assigned […] - 2025-03-07 06:59:02
- Is Regeneron Pharmaceuticals Stock Underperforming the Dow?
- Regeneron Pharmaceuticals has underperformed the Dow over the past year, but analysts are highly optimistic about the stock’s prospects. - 2025-03-06 18:56:03
- Is Regeneron Pharmaceuticals Stock Underperforming the Dow?
- Regeneron Pharmaceuticals has underperformed the Dow over the past year, but analysts are highly optimistic about the stock’s prospects. - 2025-03-06 16:25:17
- Sigma Planning Corp Has $557,000 Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
- Sigma Planning Corp grew its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 91.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 782 shares of the biopharmaceutical company’s stock after acquiring an additional 373 shares during the quarter. Sigma Planning […] - 2025-02-27 09:05:02
- D.A. Davidson & CO. Decreases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
- D.A. Davidson & CO. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 753 shares of the biopharmaceutical company’s stock after selling 68 shares during the quarter. D.A. Davidson & CO.’s […] - 2025-02-26 09:01:06
- Regeneron Pharmaceuticals Stock: Analyst Estimates & Ratings
- Despite Regeneron Pharmaceuticals’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects. - 2025-02-25 14:31:43
- Regeneron Pharmaceuticals Stock: Analyst Estimates & Ratings
- Despite Regeneron Pharmaceuticals’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects. - 2025-02-25 12:27:45
- Regeneron Pharmaceuticals Stock: Analyst Estimates & Ratings
- Despite Regeneron Pharmaceuticals’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects. - 2025-02-25 10:21:20
- Regeneron Pharmaceuticals Stock: Analyst Estimates & Ratings
- Despite Regeneron Pharmaceuticals’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects. - 2025-02-25 07:47:47
- Regeneron & Sanofi : FDA Accepts Dupixent SBLA For Priority Review In Bullous Pemphigoid Treatment
- (RTTNews) - The U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application or sBLA for Dupixent (dupilumab) to treat adults with bullous pemphigoid, Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNYNF, SNY) said in a stat - 2025-02-18 06:25:28
- Regeneron and Sanofi Announce FDA Priority Review for Dupixent® as Potential First Targeted Treatment for Bullous Pemphigoid
- Dupixent may become the first targeted treatment for bullous pemphigoid in the U.S., pending FDA approval by June 2025. - 2025-02-18 06:10:25
- Fund Update: Applied Finance Capital Management, LLC Just Disclosed New Holdings
- Applied Finance Capital Management, LLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other fun - 2025-02-13 15:04:32
- Kingsview Wealth Management LLC Raises Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
- Kingsview Wealth Management LLC raised its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 16.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,002 shares of the biopharmaceutical company’s stock after acquiring an additional 142 […] - 2025-02-13 09:55:09
- U.S. Capital Wealth Advisors LLC Has $306,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
- U.S. Capital Wealth Advisors LLC lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 80.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 429 shares of the biopharmaceutical company’s stock after selling 1,746 shares during the quarter. U.S. Capital […] - 2025-02-07 10:16:49
- Regeneron Pharmaceuticals (NASDAQ:REGN) Raised to “Strong-Buy” at Leerink Partnrs
- Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was upgraded by stock analysts at Leerink Partnrs from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. REGN has been the subject of several other research reports. Wolfe Research started coverage on shares of Regeneron Pharmaceuticals in […] - 2025-02-07 06:28:44
- Stocks Settle High on Strength in Megacap Technology Stocks
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.26%. March E-mini S&P futures (ESH25 ) rose by +0.68%, and March E-mini Nasdaq futures... - 2025-02-05 14:36:07
iShares Russell 1000 Growth UCITS ETF USD Acc REGN holdings
| Date | Number of REGN Shares Held | Base Market Value of REGN Shares | Local Market Value of REGN Shares | Change in REGN Shares Held | Change in REGN Base Value | Current Price per REGN Share Held | Previous Price per REGN Share Held |
|---|
| 2025-03-10 (Monday) | 64 | USD 47,669 | USD 47,669 | 0 | USD 2,388 | USD 744.828 | USD 707.516 |
| 2025-03-07 (Friday) | 64 | USD 45,281 | USD 45,281 | 0 | USD 1,303 | USD 707.516 | USD 687.156 |
| 2025-03-05 (Wednesday) | 64 | USD 43,978 | USD 43,978 | 0 | USD 747 | USD 687.156 | USD 675.484 |
| 2025-03-04 (Tuesday) | 64 | USD 43,231 | USD 43,231 | 0 | USD -601 | USD 675.484 | USD 684.875 |
| 2025-03-03 (Monday) | 64 | USD 43,832 | USD 43,832 | 0 | USD -887 | USD 684.875 | USD 698.734 |
| 2025-02-28 (Friday) | 64 | USD 44,719 | USD 44,719 | 0 | USD -259 | USD 698.734 | USD 702.781 |
| 2025-02-27 (Thursday) | 64 | USD 44,978 | USD 44,978 | 1 | USD 441 | USD 702.781 | USD 706.937 |
| 2025-02-26 (Wednesday) | 63 | USD 44,537 | USD 44,537 | 0 | USD -1,042 | USD 706.937 | USD 723.476 |
| 2025-02-25 (Tuesday) | 63 | USD 45,579 | USD 45,579 | -1 | USD -69 | USD 723.476 | USD 713.25 |
| 2025-02-24 (Monday) | 64 | USD 45,648 | USD 45,648 | -1 | USD 127 | USD 713.25 | USD 700.323 |
| 2025-02-21 (Friday) | 65 | USD 45,521 | USD 45,521 | 0 | USD 280 | USD 700.323 | USD 696.015 |
| 2025-02-20 (Thursday) | 65 | USD 45,241 | USD 45,241 | 0 | USD 673 | USD 696.015 | USD 685.662 |
| 2025-02-19 (Wednesday) | 65 | USD 44,568 | USD 44,568 | 0 | USD 368 | USD 685.662 | USD 680 |
| 2025-02-18 (Tuesday) | 65 | USD 44,200 | USD 44,200 | 0 | USD 416 | USD 680 | USD 673.6 |
| 2025-02-17 (Monday) | 65 | USD 43,784 | USD 43,784 | 0 | USD 0 | USD 673.6 | USD 673.6 |
| 2025-02-14 (Friday) | 65 | USD 43,784 | USD 43,784 | 0 | USD -44 | USD 673.6 | USD 674.277 |
| 2025-02-13 (Thursday) | 65 | USD 43,828 | USD 43,828 | 0 | USD 677 | USD 674.277 | USD 663.862 |
| 2025-02-12 (Wednesday) | 65 | USD 43,151 | USD 43,151 | 0 | USD -104 | USD 663.862 | USD 665.462 |
| 2025-02-11 (Tuesday) | 65 | USD 43,255 | USD 43,255 | 0 | USD -1,618 | USD 665.462 | USD 690.354 |
| 2025-02-10 (Monday) | 65 | USD 44,873 | USD 44,873 | 0 | USD -1,277 | USD 690.354 | USD 710 |
| 2025-02-07 (Friday) | 65 | USD 46,150 | USD 46,150 | 0 | USD -785 | USD 710 | USD 722.077 |
| 2025-02-06 (Thursday) | 65 | USD 46,935 | USD 46,935 | 1 | USD 1,065 | USD 722.077 | USD 716.719 |
| 2025-02-05 (Wednesday) | 64 | USD 45,870 | USD 45,870 | 1 | USD 1,956 | USD 716.719 | USD 697.048 |
| 2025-02-04 (Tuesday) | 63 | USD 43,914 | USD 43,914 | 0 | USD 1,902 | USD 697.048 | USD 666.857 |
| 2025-02-03 (Monday) | 63 | USD 42,012 | USD 42,012 | 0 | USD -386 | USD 666.857 | USD 672.984 |
| 2025-01-31 (Friday) | 63 | USD 42,398 | USD 42,398 | 0 | USD -636 | USD 672.984 | USD 683.079 |
| 2025-01-30 (Thursday) | 63 | USD 43,034 | USD 43,034 | 0 | USD -264 | USD 683.079 | USD 687.27 |
| 2025-01-29 (Wednesday) | 63 | USD 43,298 | USD 43,298 | 0 | USD 59 | USD 687.27 | USD 686.333 |
| 2025-01-28 (Tuesday) | 63 | USD 43,239 | USD 43,239 | 0 | USD 102 | USD 686.333 | USD 684.714 |
| 2025-01-27 (Monday) | 63 | USD 43,137 | USD 43,137 | 0 | USD 562 | USD 684.714 | USD 675.794 |
| 2025-01-24 (Friday) | 63 | USD 42,575 | USD 42,575 | 0 | USD -1,187 | USD 675.794 | USD 694.635 |
| 2025-01-23 (Thursday) | 63 | USD 43,762 | USD 43,762 | 0 | USD 920 | USD 694.635 | USD 680.032 |
| 2025-01-22 (Wednesday) | 63 | USD 42,842 | USD 42,842 | | | | |
| 2025-01-21 (Tuesday) | 61 | USD 41,956 | USD 41,956 | | | | |
| 2025-01-20 (Monday) | 57 | USD 38,850 | USD 38,850 | | | | |
| 2025-01-17 (Friday) | 57 | USD 38,850 | USD 38,850 | | | | |
| 2025-01-16 (Thursday) | 57 | USD 39,514 | USD 39,514 | | | | |
| 2025-01-15 (Wednesday) | 54 | USD 37,985 | USD 37,985 | | | | |
| 2025-01-14 (Tuesday) | 54 | USD 37,307 | USD 37,307 | | | | |
| 2025-01-13 (Monday) | 54 | USD 38,713 | USD 38,713 | | | | |
| 2025-01-10 (Friday) | 54 | USD 37,632 | USD 37,632 | | | | |
| 2025-01-09 (Thursday) | 54 | USD 39,614 | USD 39,614 | | | | |
| 2025-01-09 (Thursday) | 54 | USD 39,614 | USD 39,614 | | | | |
| 2025-01-09 (Thursday) | 54 | USD 39,614 | USD 39,614 | | | | |
| 2025-01-08 (Wednesday) | 54 | USD 39,614 | USD 39,614 | | | | |
| 2025-01-08 (Wednesday) | 54 | USD 39,614 | USD 39,614 | | | | |
| 2025-01-08 (Wednesday) | 54 | USD 39,614 | USD 39,614 | | | | |
| 2024-12-10 (Tuesday) | 48 | USD 37,368 | USD 37,368 | 1 | USD 332 | USD 778.5 | USD 788 |
| 2024-12-09 (Monday) | 47 | USD 37,036 | USD 37,036 | 1 | USD 1,248 | USD 788 | USD 778 |
| 2024-12-06 (Friday) | 46 | USD 35,788 | USD 35,788 | 0 | USD 465 | USD 778 | USD 767.891 |
| 2024-12-05 (Thursday) | 46 | USD 35,323 | USD 35,323 | 0 | USD 627 | USD 767.891 | USD 754.261 |
| 2024-12-04 (Wednesday) | 46 | USD 34,696 | USD 34,696 | 0 | USD 216 | USD 754.261 | USD 749.565 |
| 2024-12-03 (Tuesday) | 46 | USD 34,480 | USD 34,480 | 0 | USD -588 | USD 749.565 | USD 762.348 |
| 2024-12-02 (Monday) | 46 | USD 35,068 | USD 35,068 | -1 | USD -192 | USD 762.348 | USD 750.213 |
| 2024-11-29 (Friday) | 47 | USD 35,260 | USD 35,260 | 0 | USD -219 | USD 750.213 | USD 754.872 |
| 2024-11-28 (Thursday) | 47 | USD 35,479 | USD 35,479 | 0 | USD 0 | USD 754.872 | USD 754.872 |
| 2024-11-27 (Wednesday) | 47 | USD 35,479 | USD 35,479 | 0 | USD 87 | USD 754.872 | USD 753.021 |
| 2024-11-26 (Tuesday) | 47 | USD 35,392 | USD 35,392 | 0 | USD 165 | USD 753.021 | USD 749.511 |
| 2024-11-25 (Monday) | 47 | USD 35,227 | USD 35,227 | 1 | USD 1,279 | USD 749.511 | USD 738 |
| 2024-11-22 (Friday) | 46 | USD 33,948 | USD 33,948 | 0 | USD -299 | USD 738 | USD 744.5 |
| 2024-11-21 (Thursday) | 46 | USD 34,247 | USD 34,247 | 0 | USD 53 | USD 744.5 | USD 743.348 |
| 2024-11-20 (Wednesday) | 46 | USD 34,194 | USD 34,194 | 0 | USD -58 | USD 743.348 | USD 744.609 |
| 2024-11-19 (Tuesday) | 46 | USD 34,252 | USD 34,252 | 0 | USD -800 | USD 744.609 | USD 762 |
| 2024-11-18 (Monday) | 46 | USD 35,052 | USD 35,052 | 0 | USD -2,714 | USD 762 | USD 821 |
| 2024-11-12 (Tuesday) | 46 | USD 37,766 | USD 37,766 | 0 | USD -341 | USD 821 | USD 828.413 |
| 2024-11-08 (Friday) | 46 | USD 38,107 | USD 38,107 | 3 | USD 2,654 | USD 828.413 | USD 824.488 |
| 2024-11-07 (Thursday) | 43 | USD 35,453 | USD 35,453 | 0 | USD 337 | USD 824.488 | USD 816.651 |
| 2024-11-06 (Wednesday) | 43 | USD 35,116 | USD 35,116 | 1 | USD 280 | USD 816.651 | USD 829.429 |
| 2024-11-05 (Tuesday) | 42 | USD 34,836 | USD 34,836 | 0 | USD 25 | USD 829.429 | USD 828.833 |
| 2024-11-04 (Monday) | 42 | USD 34,811 | USD 34,811 | 0 | USD -620 | USD 828.833 | USD 843.595 |
| 2024-11-01 (Friday) | 42 | USD 35,431 | USD 35,431 | 0 | USD 227 | USD 843.595 | USD 838.19 |
| 2024-10-31 (Thursday) | 42 | USD 35,204 | USD 35,204 | 0 | USD -3,553 | USD 838.19 | USD 922.786 |
| 2024-10-30 (Wednesday) | 42 | USD 38,757 | USD 38,757 | 1 | USD 736 | USD 922.786 | USD 927.341 |
| 2024-10-29 (Tuesday) | 41 | USD 38,021 | USD 38,021 | 0 | USD -52 | USD 927.341 | USD 928.61 |
| 2024-10-28 (Monday) | 41 | USD 38,073 | USD 38,073 | 0 | USD -181 | USD 928.61 | USD 933.024 |
| 2024-10-25 (Friday) | 41 | USD 38,254 | USD 38,254 | 0 | USD 169 | USD 933.024 | USD 928.902 |
| 2024-10-24 (Thursday) | 41 | USD 38,085 | USD 38,085 | 0 | USD -512 | USD 928.902 | USD 941.39 |
| 2024-10-23 (Wednesday) | 41 | USD 38,597 | USD 38,597 | 0 | USD -859 | USD 941.39 | USD 962.341 |
| 2024-10-22 (Tuesday) | 41 | USD 39,456 | USD 39,456 | -18 | USD -17,686 | USD 962.341 | USD 968.508 |
| 2024-10-21 (Monday) | 59 | USD 57,142 | USD 57,142 | 0 | USD -1,308 | USD 968.508 | USD 990.678 |
| 2024-10-18 (Friday) | 59 | USD 58,450 | USD 58,450 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of REGN by Blackrock for IE000NITTFF2
Show aggregate share trades of REGN| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-02-27 | BUY | 1 | | | 702.781* | | 763.13 |
| 2025-02-25 | SELL | -1 | | | 723.476* | | 764.84 Profit of 765 on sale |
| 2025-02-24 | SELL | -1 | | | 713.250* | | 765.78 Profit of 766 on sale |
| 2025-02-06 | BUY | 1 | | | 722.077* | | 787.96 |
| 2025-02-05 | BUY | 1 | | | 716.719* | | 789.66 |
| 2024-12-10 | BUY | 1 | | | 778.500* | | 819.95 |
| 2024-12-09 | BUY | 1 | | | 788.000* | | 820.98 |
| 2024-12-02 | SELL | -1 | | | 762.348* | | 832.25 Profit of 832 on sale |
| 2024-11-25 | BUY | 1 | | | 749.511* | | 851.24 |
| 2024-11-08 | BUY | 3 | | | 828.413* | | 892.44 |
| 2024-11-06 | BUY | 1 | | | 816.651* | | 904.41 |
| 2024-10-30 | BUY | 1 | | | 922.786* | | 941.45 |
| 2024-10-22 | SELL | -18 | | | 962.341* | | 968.51 Profit of 17,433 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of REGN
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-03-11 | 231,740 | 516 | 380,736 | 60.9% |
| 2025-03-10 | 352,172 | 11,278 | 615,468 | 57.2% |
| 2025-03-07 | 215,927 | 9,258 | 386,917 | 55.8% |
| 2025-03-06 | 176,500 | 1,924 | 319,286 | 55.3% |
| 2025-03-05 | 131,021 | 556 | 227,296 | 57.6% |
| 2025-03-04 | 208,515 | 1,467 | 426,660 | 48.9% |
| 2025-03-03 | 153,209 | 359 | 225,560 | 67.9% |
| 2025-02-28 | 247,960 | 5,515 | 347,710 | 71.3% |
| 2025-02-27 | 111,440 | 334 | 190,691 | 58.4% |
| 2025-02-26 | 118,100 | 457 | 226,356 | 52.2% |
| 2025-02-25 | 211,116 | 5,554 | 372,181 | 56.7% |
| 2025-02-24 | 178,008 | 8,770 | 305,357 | 58.3% |
| 2025-02-21 | 105,063 | 265 | 195,287 | 53.8% |
| 2025-02-20 | 116,787 | 2,703 | 213,405 | 54.7% |
| 2025-02-19 | 105,289 | 1,670 | 200,251 | 52.6% |
| 2025-02-18 | 123,632 | 506 | 239,666 | 51.6% |
| 2025-02-14 | 116,765 | 561 | 237,478 | 49.2% |
| 2025-02-13 | 131,074 | 72 | 246,188 | 53.2% |
| 2025-02-12 | 162,321 | 546 | 438,185 | 37.0% |
| 2025-02-11 | 208,010 | 661 | 468,691 | 44.4% |
| 2025-02-10 | 191,197 | 431 | 326,916 | 58.5% |
| 2025-02-07 | 171,758 | 328 | 372,591 | 46.1% |
| 2025-02-06 | 194,473 | 2,700 | 361,046 | 53.9% |
| 2025-02-05 | 230,112 | 1,423 | 557,469 | 41.3% |
| 2025-02-04 | 344,419 | 2,808 | 713,550 | 48.3% |
| 2025-02-03 | 132,533 | 102 | 390,271 | 34.0% |
| 2025-01-31 | 170,901 | 3,128 | 388,058 | 44.0% |
| 2025-01-30 | 161,310 | 810 | 308,799 | 52.2% |
| 2025-01-29 | 84,014 | 179 | 196,928 | 42.7% |
| 2025-01-28 | 110,084 | 131 | 251,672 | 43.7% |
| 2025-01-27 | 136,829 | 1,628 | 456,666 | 30.0% |
| 2025-01-24 | 103,777 | 147 | 472,499 | 22.0% |
| 2025-01-23 | 129,070 | 1,227 | 480,995 | 26.8% |
| 2025-01-22 | 100,141 | 345 | 378,445 | 26.5% |
| 2025-01-21 | 95,845 | 146 | 434,045 | 22.1% |
| 2025-01-17 | 110,844 | 3,314 | 292,799 | 37.9% |
| 2025-01-16 | 130,813 | 431 | 317,721 | 41.2% |
| 2025-01-15 | 139,590 | 1,845 | 308,628 | 45.2% |
| 2025-01-14 | 141,278 | 516 | 321,372 | 44.0% |
| 2025-01-13 | 236,079 | 806 | 586,332 | 40.3% |
| 2025-01-10 | 187,045 | 496 | 489,406 | 38.2% |
| 2025-01-08 | 114,813 | 503 | 263,698 | 43.5% |
| 2025-01-07 | 111,771 | 685 | 284,647 | 39.3% |
| 2025-01-06 | 134,121 | 208 | 310,501 | 43.2% |
| 2025-01-03 | 84,838 | 7,306 | 220,748 | 38.4% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.